Ignite Creation Date:
2025-12-25 @ 3:14 AM
Ignite Modification Date:
2026-03-22 @ 3:10 PM
Study NCT ID:
NCT00398905
Status:
COMPLETED
Last Update Posted:
2009-05-08
First Post:
2006-11-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
10944
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Therapeutic Area Head
Old Organization:
Bayer Healthcare AG